Abstract:
The invention provides a method for monitoring the progression of a myeloproliferative disease, particularly Polycythemia Vera (PV) and Essential Thrombocythemia (ET), or the response to pharmacological treatment with JAK2 inhibitors in a patient diagnosed positive for the same disease, or a method for predicting thrombotic events in a patient affected by the same myeloproliferative diseases, based on the measurement of PTX3 concentration in a blood, plasma or serum sample.
Abstract:
Method for determining the level of PTX3 protein in a sample of a biological fluid; hybridoma capable of producing a rat anti-PTX3 monoclonal antibody where said hybridoma is selected from the group comprising MNB10 and Pen-3; specific anti-PTX3 rat monoclonal antibody selected from the monoclonal antibodies produced by the hybridomas MNB10 and Pen-3; kit for determining the level of PTX3 protein in a biological fluid wherein the said kit includes a rat anti-PTX3 monoclonal antibody.
Abstract:
Devices and systems are provided which may be used to navigate and communicate while diving in dive sites and improve the safety of the diving experience. For example, in certain embodiments, a diver area system is provided which utilizes virtual underwater information to provide the user with their location, the location of other divers (or “buddies”), and/or location of a surface object (e.g., a dive boat). In certain embodiments, the devices and systems disclosed herein may provide user with their location relative to one or more buddies. The user can thus navigate intelligently throughout the dive site and track the location of their buddies which can improve dive safety and/or efficiency. Additionally, the user can communicate with one or more buddy divers and/or surface-based objects and individuals using embodiments of the disclosure.
Abstract:
The present invention relates to a G-protein coupled receptor and a novel ligand therefor. The invention provides screening assays for the identification of candidate compounds which modulate the activity of the G-protein coupled receptor, as well as assays useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of G-protein coupled receptor signaling.
Abstract:
A method for the early determination of the risk of death or heart failure in infarction patients, and the risk of death, relapse or complications in ictus patients, the method being based on the determination of PTX3 from plasma or blood.
Abstract:
The present invention relates to a G-protein coupled receptor and a novel ligand therefor. The invention provides screeing assays for the identification of candidate compounds which modulate the activity of the G-protein coupled receptor, as well as assays useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of G-protein coupled receptor signaling.
Abstract:
The line interface circuit of a modem to be connected to a standard RJ11 jack of a digital PBX (Private Branch Exchange) is used along with software routines resident in the modem to detect the presence of a PBX connected to the modem. Upon going off-hook, the modem, by the software routines, determines whether the connection will harm the interface by one of several software routines. If it appears that the interface circuit may be damaged because a PBX line is present, the modem is instructed to go on-hook (hang up), or if the connection is not harmful to the interface, alerts the user that the modem is connected to a wrong jack.
Abstract:
The present invention relates to a G-protein coupled receptor and a novel ligand therefor. The invention provides screening assays for the identification of candidate compounds which modulate the activity of the G-protein coupled receptor, as well as assays useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of G-protein coupled receptor signaling.
Abstract:
Pharmaceutical compositions are described containing a long pentraxin PTX3, particularly human PTX3, for the therapy of infectious and inflammatory or tumor diseases; expression vectors containing cDNA coding for PTX3; recombinant host cells transfected with such vectors; a method for producing substantial amounts of PTX3 involving the culturing of such cells, and the use of said vectors in the gene therapy of tumors.
Abstract:
The present invention relates to a G-protein coupled receptor and a novel ligand therefor. The invention provides screening assays for the identification of candidate compounds which modulate the activity of the G-protein coupled receptor, as well as assays useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of G-protein coupled receptor signaling.